Minolis | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Minolis
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Minolis

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 15 USDMF, 7 CEP/COS, 3 JDMF, 2 KDMF, 12 NDC API, 15 Listed Suppliers, $ API Reference Price

32 API Suppliers
15 USDMF
7 CEP/COS
3 JDMF
2 KDMF
12 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

117 Drugs in Development

117 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

179 FDF Dossiers, 138 FDA Orange Book, 3 Europe, 7 Canada, 4 Australia, 6 South Africa, 21 Listed Dossiers

179 FDF Dossiers
138 FDA Orange Book
3 Europe
7 Canada
4 Australia
6 South Africa
21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE, CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
CAPSULE;ORAL - EQ 100MG BASE
CAPSULE;ORAL - EQ 50MG BASE
CAPSULE;ORAL - EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
POWDER, EXTENDED RELEASE;DENTAL - EQ 1MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 105MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 115MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 135MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 55MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 65MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 80MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 10 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 27 BASF, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 29 Direct Compression, 29 Thickeners and Stabilizers, 28 Granulation, 27 Lubricants & Glidants, 24 Solubilizers, 24 Controlled & Modified Release, 19 Film Formers & Plasticizers, 19 Disintegrants & Superdisintegrants, 19 Topical, 13 Parenteral, 13 Co-Processed Excipients, 10 Taste Masking, 9 Empty Capsules, 9 Emulsifying Agents, 8 Chewable & Orodispersible Aids, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules

59 Fillers, Diluents & Binders
47 Coating Systems & Additives
29 Direct Compression
29 Thickeners and Stabilizers
28 Granulation
27 Lubricants & Glidants
24 Solubilizers
24 Controlled & Modified Release
19 Film Formers & Plasticizers
19 Disintegrants & Superdisintegrants
19 Topical
13 Parenteral
13 Co-Processed Excipients
10 Taste Masking
9 Empty Capsules
9 Emulsifying Agents
8 Chewable & Orodispersible Aids
6 Surfactant & Foaming Agents
6 API Stability Enhancers
6 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 73 News #PharmaBuzz

1 Data Compilation #PharmaFlow
73 News #PharmaBuzz

GLOBAL SALES INFORMATION

21 US Medicaid Prescriptions, 21 Regulatory FDF Prices, 4 Annual Reports

21 US Medicaid Prescriptions
21 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

34 APIs, 2 FDF Dossiers

34 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

87 US Patents, 1 US Exclusivities, 1 Health Canada Patents

87 US Patents
1 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 Others

2 EDQM
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,246 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Johnson & Johnson Inc.

filter Patent Reset all filters

1 All

01 11330533

filter Product Reset all filters

1 All

01 1Minocycline Hydrochloride

filter Dosage Reset all filters

1 All

01 1Extended Release Powder

filter Exp Date Reset all filters

1 All

01 12011-07-05

Suanfarma Minocycline Hydrochloride

Product Main Page

01

Johnson & Johnson Inc.

Minocycline Hydrochloride

Peptide Process CMC

Not Confirmed

Johnson & Johnson Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-05

Date Granted : 1994-07-05

Minocycline Hydrochloride

Brand Name : ARESTIN MICROSPHERES

Patent Number : 1330533

Filing Date : 1988-05-24

Strength per Unit : 1mg/4mg Cartridge

Dosage Form : Extended Release Powder

Human Or VET : Human

Route of Administration : Sub Gingival

Patent Expiration Date : 2011-07-05

Date Granted : 1994-07-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!